UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 110

Sortiert nach

Dynamic Mode Decomposition: A Tool to Extract Structures Hidden in Massive Datasets

Data Analysis for Direct Numerical Simulations of Turbulent Combustion, 2020, p.157-176

2020

Link zum Volltext

Verfügbarkeit prüfen

Higher Order Tensors for DNS Data Analysis and Compression

Data Analysis for Direct Numerical Simulations of Turbulent Combustion, 2020, p.109-134

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Flame Topology and Burning Rates

Data Analysis for Direct Numerical Simulations of Turbulent Combustion, 2020, p.1-17

2020

Link zum Volltext

Verfügbarkeit prüfen

Incidence of gallstone disease in Italy：Results from a multicenter,population-based Italian study （the MICOL project）

World journal of gastroenterology : WJG, 2008, Vol.14 (34), p.5282-5289

Davide Festi Ada Dormi Simona Capodicasa Tommaso Staniscia Adolfo F Attili Paola Loria Paolo Pazzi Giuseppe Mazzella Claudia Sama Enrico Roda Antonio Colecchia

2008

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2022-09, Vol.40 (25), p.2871-2877

2022

Link zum Volltext

Verfügbarkeit prüfen

The human gut microbiota and virome: Potential therapeutic implications

Digestive and liver disease, 2015-12, Vol.47 (12), p.1007-1012

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project)

World journal of gastroenterology : WJG, 2008-09, Vol.14 (34), p.5282-5289

2008

Link zum Volltext

Verfügbarkeit prüfen

CheckMate 9LA: broadening treatment options for patients with non-small-cell lung cancer

The lancet oncology, 2021-02, Vol.22 (2), p.157-159

2021

Link zum Volltext

Verfügbarkeit prüfen

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

Current oncology (Toronto), 2022-01, Vol.29 (1), p.255-266

2022

Link zum Volltext

Verfügbarkeit prüfen

Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study

Journal of gastroenterology and hepatology, 2010-04, Vol.25 (4), p.719-724

2010

Link zum Volltext

Verfügbarkeit prüfen

Strategies to overcome resistance to immune checkpoint blockade in lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-04, Vol.154, p.151-160

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data

Cancer treatment reviews, 2020-09, Vol.89, p.102085-102085, Article 102085

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathological and virological insights from an outbreak of European brown hare syndrome in the Italian hare (Lepus corsicanus)

Frontiers in microbiology, 2023-10, Vol.14, p.1250787-1250787

2023

Link zum Volltext

Verfügbarkeit prüfen

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations

Cancers, 2021-04, Vol.13 (9), p.2172

2021

Link zum Volltext

Verfügbarkeit prüfen

Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?

Critical reviews in oncology/hematology, 2017-11, Vol.119, p.30-39

2017

Link zum Volltext

Verfügbarkeit prüfen

Overcoming resistance to osimertinib in non–small cell lung cancer: Hopes, doubts, and in‐between

Cancer, 2020-06, Vol.126 (11), p.2594-2596

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review

Cancer treatment reviews, 2023-09, Vol.119, p.102602-102602, Article 102602

2023

Link zum Volltext

Verfügbarkeit prüfen

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3160-3175

2023

Link zum Volltext

Verfügbarkeit prüfen

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations

Cancers, 2023-10, Vol.15 (20), p.5079

2023

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis

Journal of hepatology, 2004-12, Vol.41 (6), p.905-912

2004

Link zum Volltext

Verfügbarkeit prüfen

Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours

Cancer treatment reviews, 2022-03, Vol.104, p.102340-102340, Article 102340

2022

Link zum Volltext

Verfügbarkeit prüfen

Estrogens and Insulin-Like Growth Factor 1 Modulate Neoplastic Cell Growth in Human Cholangiocarcinoma

The American journal of pathology, 2006-09, Vol.169 (3), p.877-888

2006

Link zum Volltext

Verfügbarkeit prüfen

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target

Cancers, 2023-09, Vol.15 (19), p.4779

2023

Link zum Volltext

Verfügbarkeit prüfen

Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials

Cancers, 2024-07, Vol.16 (13), p.2457

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50

Frontiers in oncology, 2022-08, Vol.12, p.980765-980765

2022

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 110

Suche als RSS-Feed

Aktive Filter

ThemaEngineering

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(59)
Humans
(36)
Gastroenterology & Hepatology
(24)
Male
(24)
Oncology
(24)
Female
(22)
Middle Aged
(16)
Aged
(12)
Lung Cancer
(12)
Nsclc
(11)
Adult
(10)
Biological And Medical Sciences
(10)
Patients
(9)
Immunotherapy
(8)
Italy
(8)
Lung Neoplasms - Drug Therapy
(8)
Medical Sciences
(8)
Cancer
(7)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dynamic Mode Decomposition: A Tool to Extract Structures Hidden in Massive Datasets

Higher Order Tensors for DNS Data Analysis and Compression

Analysis of Flame Topology and Burning Rates

Incidence of gallstone disease in Italy：Results from a multicenter,population-based Italian study （the MICOL project）

Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non–Small-Cell Lung Cancer

The human gut microbiota and virome: Potential therapeutic implications

Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project)

CheckMate 9LA: broadening treatment options for patients with non-small-cell lung cancer

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study

Strategies to overcome resistance to immune checkpoint blockade in lung cancer

Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data

Pathological and virological insights from an outbreak of European brown hare syndrome in the Italian hare (Lepus corsicanus)

Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations

Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?

Overcoming resistance to osimertinib in non–small cell lung cancer: Hopes, doubts, and in‐between

Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations

Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis

Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours

Estrogens and Insulin-Like Growth Factor 1 Modulate Neoplastic Cell Growth in Human Cholangiocarcinoma

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target

Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50

Aktive Filter

Suchergebnisse filtern